UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors

Frontiers in immunology, 2020-01, Vol.10, p.3038-3038

2020

Volltextzugriff (PDF)

Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma

Nature communications, 2020-11, Vol.11 (1), p.5992-5992, Article 5992

2020

Volltextzugriff (PDF)

Inhibition of Natural Killer Cell Cytotoxicity by Interleukin‐6: Implications for the Pathogenesis of Macrophage Activation Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2015-11, Vol.67 (11), p.3037-3046

2015

Volltextzugriff (PDF)

DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?

International journal of molecular sciences, 2019-07, Vol.20 (15), p.3715

2019

Volltextzugriff (PDF)

PlGF Immunological Impact during Pregnancy

International journal of molecular sciences, 2020-11, Vol.21 (22), p.8714

2020

Volltextzugriff (PDF)

The immune system view of the coronavirus SARS-CoV-2

Biology direct, 2020-12, Vol.15 (1), p.30-30, Article 30

2020

Volltextzugriff (PDF)

Polyphenol-Mediated Autophagy in Cancer: Evidence of In Vitro and In Vivo Studies

International journal of molecular sciences, 2020-09, Vol.21 (18), p.6635

2020

Volltextzugriff (PDF)

Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer

Frontiers in immunology, 2020-06, Vol.11, p.1132-1132

2020

Volltextzugriff (PDF)

Role of endoplasmic reticulum aminopeptidases in health and disease: from infection to cancer

International Journal of Molecular Sciences, 2012-07, Vol.13 (7), p.8338-8352

2012

Volltextzugriff (PDF)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy

Frontiers in immunology, 2023-06, Vol.14, p.1197053-1197053

2023

Volltextzugriff (PDF)

The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival

International journal of molecular sciences, 2023-12, Vol.25 (1), p.232

2023

Volltextzugriff (PDF)

Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice

International journal of molecular sciences, 2024-06, Vol.25 (11), p.6259

2024

Volltextzugriff (PDF)

DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study

Frontiers in immunology, 2022-07, Vol.13, p.886319-886319

2022

Volltextzugriff (PDF)

Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission

Viruses, 2024-05, Vol.16 (5), p.780

2024

Volltextzugriff (PDF)

Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo

Journal of translational medicine, 2022-06, Vol.20 (1), p.1-286, Article 286

2022

Volltextzugriff (PDF)

IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma

PloS one, 2012-10, Vol.7 (10), p.e46928-e46928

2012

Volltextzugriff (PDF)

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

Frontiers in immunology, 2021-11, Vol.12, p.778103-778103

2021

Volltextzugriff (PDF)

Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors

Cancer immunology research, 2021-02, Vol.9 (2), p.170-183

2021

Volltextzugriff (PDF)

IFNAR2 Deficiency Causing Dysregulation of NK Cell Functions and Presenting With Hemophagocytic Lymphohistiocytosis

Frontiers in genetics, 2020-09, Vol.11, p.937-937

2020

Volltextzugriff (PDF)

Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers

PloS one, 2017-12, Vol.12 (12), p.e0189615-e0189615

2017

Volltextzugriff (PDF)

Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma

Frontiers in medicine, 2023-02, Vol.10, p.1066021-1066021

2023

Volltextzugriff (PDF)

GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e001502

2021

Volltextzugriff (PDF)

Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors

Oncoimmunology, 2019-02, Vol.8 (2), p.e1542245

2019

Volltextzugriff (PDF)

MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma

Oncoimmunology, 2017-06, Vol.6 (6), p.e1316439-e1316439

2017

Volltextzugriff (PDF)

Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome

Cancers, 2021-08, Vol.13 (17), p.4368

2021

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(59)
Berichte
(1)

Sprache

Englisch
(60)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors

Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma

Inhibition of Natural Killer Cell Cytotoxicity by Interleukin‐6: Implications for the Pathogenesis of Macrophage Activation Syndrome

DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?

PlGF Immunological Impact during Pregnancy

The immune system view of the coronavirus SARS-CoV-2

Polyphenol-Mediated Autophagy in Cancer: Evidence of In Vitro and In Vivo Studies

Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer

Role of endoplasmic reticulum aminopeptidases in health and disease: from infection to cancer

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy

The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival

Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice

DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study

Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission

Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo

IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors

IFNAR2 Deficiency Causing Dysregulation of NK Cell Functions and Presenting With Hemophagocytic Lymphohistiocytosis

Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers

Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma

GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape

Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors

MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma

Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome

Suchergebnisse filtern